Kevin Arnett, a former prisoner at the Bureau of Prisons Federal Correctional Complex in Terre Haute, Indiana, brought this
Bivens
action,
see Bivens v. Six Unknown Named Agents of Fed. Bureau of Narcotics,
Because Enbrel wasn’t on the prison’s approved formulary, prison medical personnel had to seek prior approval to prescribe the medication by submitting a nonformulary drug authorization request to the Central Office of the Bureau of Prisons in Washington, D.C. (BOP) Dr. Webster submitted a request for Arnett to receive Gabapentin, used to treat nerve pain, but not Enbrel, and also submitted approval for a consultation with an outside rheumatologist. W. Eric Wilson, M.D., staff physician at Terre Haute, became Arnett’s pri *746 mary care physician on December 28, 2006. An outside rheumatologist examined Arnett in February 2007, and it can be inferred that he directed Dr. Wilson to place Arnett back on Enbrel. Despite the rheumatologist’s instruction and Arnett’s repeated pleas for the medication and complaints of continued pain and swelling, he didn’t receive Enbrel until October 5, 2007, eleven days before he was transferred from the facility to a halfway house. Ar-nett was told by the defendants during the more than ten months he waited for the drug that the non-formulary request had been submitted, they were waiting for a response from the BOP, and were otherwise “working on it.” In the meantime, Arnett was prescribed pain medicine, but nothing to treat the inflammation and deterioration of his joints.
Because Arnett sought leave to proceed in forma pauperis, the district court screened his complaint pursuant to 28 U.S.C. § 1915(e)(2)(B), and in so doing, dismissed all the defendants, except Dr. Webster, on the basis that Arnett failed to state a claim upon which relief could be granted. (Shortly after screening, Ar-nett’s case was transferred from Judge Richard L. Young to Judge William T. Lawrence.) Dr. Webster then filed a summary judgment motion and the district court granted that motion. The district court entered judgment, directing that plaintiff take nothing by his complaint. Arnett appeals both rulings and we affirm in part and reverse in part. We affirm dismissal of the non-medical defendants on the pleadings, but find that Arnett properly stated a claim against the medical defendants. We, however, affirm the district court’s grant of summary judgment in favor of Dr. Webster because Arnett failed to meet his burden to submit evidence upon which a reasonable jury could find that Dr. Webster acted with deliberate indifference.
I. Facts
Arnett brought this suit against the following Terre Haute prison employees for violation of his Eighth Amendment rights: Warden Richard Veach, Health Services Administrator Julia Beighley, Case Manager David Parker, Staff Physician W. Eric Wilson, M.D., Physician’s Assistant Yves A. Paul-Blanc, and Clinical Director Thomas A. Webster, M.D. (Arnett also sued the Federal Bureau of Prisons, but recognizing that dismissal of the BOP was proper, he has not appealed that ruling.) Because we are reviewing a dismissal at both the pleading and summary judgment stage, we begin by setting forth the allegations and facts in Arnett’s complaint and documents attached thereto.
See Reger Dev., LLC v. Nat’l City Bank,
In 2001, Arnett was diagnosed with RA by his treating physician, Steven R. Bergquist, M.D. RA involves autoimmune reactions and is a progressive disease that causes pain and inflammation in the joints. 1 After other medications proved unsuccessful in controlling his condition, Dr. Bergquist placed Arnett on the drug Enbrel in January 2004. Enbrel reduces joint swelling, helps prevent damage to the *747 joints, 2 and was effective in decreasing Ar-nett’s inflammation and accompanying pain. Enbrel is a protein that inhibits inflammation in the body by suppressing a substance produced by the immune system known as tumor necrosis factor (TNF). 3 Subsequently, Arnett was convicted of a federal criminal offense and sentenced to imprisonment. He self-surrendered at the Terre Haute prison on November 1, 2006, and when he arrived, he brought his Enbrel medication, but prison officials confiscated it upon arrival.
During the next ten months, Arnett lodged numerous oral and written complaints to the defendants for Enbrel, but to no avail. Dr. Webster examined Arnett twice in November 2006. During both exams, Arnett told Dr. Webster that he needed Enbrel to control his RA and that because he didn’t have the medication, his joints were swollen, especially his knees, and he was in intense pain; this resulted in Arnett having to walk with a cane. Dr. Webster agreed that Arnett’s joints were swollen. In response to his requests for Enbrel, Dr. Webster said, “We’ll work on it.” Dr. Webster attested that he has no recollection of meeting with Arnett or discussing his request for Enbrel. Arnett also informed Warden Veach in December 2006 that his Enbrel had been confiscated by prison employees and that he needed it to control his RA. Veach told Arnett to talk to Health Services Administrator Beighley. Arnett complained to Beighley and she told him to put his request in writing, which he did.
Dr. Wilson became Arnett’s primary physician at the prison beginning December 28, 2006; he saw Arnett every other month until his transfer from the facility in October 2007. Each time he met with Dr. Wilson, Arnett informed him he needed Enbrel and without it, he suffered from joint swelling, particularly in his knees. Dr. Wilson examined Arnett’s knees and other joints and agreed they were swollen. In response to Arnett’s request, Dr. Wilson stated that he had filled out new forms to get Enbrel that had to be sent to the BOP in Washington, D.C.
Arnett’s medical file was presented to' the prison’s utilization review committee on November 16, 2006, for consideration of Dr. Webster’s recommendation that Arnett receive a consultation with a rheumatologist for his RA; the committee concurred that review of Arnett’s condition by an outside consultant was warranted. Arnett was seen by Dr. Henry Davis, a rheumatologist, on February 7, 2007. Dr. Davis wrote a letter to Dr. Wilson that Arnett attached to his complaint. The letter explained that Arnett’s RA had caused him “acute swelling and pain in his hands, *748 wrists, knees, and neck” and that when he started on Enbrel, he did “fairly well,” but has been without it for the last four months. Dr. Davis noted that Arnett had “been taking Percocet and Norco without any benefit.” During his examination, Dr. Davis noted swelling and tenderness in different areas of Arnett’s body and gave him an injection of Depo-Medrol (medication used to treat joint pain and swelling that occurs with arthritis) in his right shoulder. He stated to Dr. Wilson, ■ “I would like for [Arnett] to resume Enbrel 15 mg once a week.” (More will be said about Dr. Davis’ comment later.) Arnett still did not receive Enbrel, so in April 2007, he again informed Veach that he needed the drug to control his RA. Veach again told Arnett to talk to Beighley. Ar-nett's medical chart dated April 4 noted that Arnett was having pain in his right knee and that he received “Enbrel injections, but that was stopped when he arrived here.”
Between February and July 2007, Ar-nett directed two more oral requests to Beighley for Enbrel. Beighley stated that a request for the medication had been submitted, but it had not arrived. On June 28, 2007, Arnett filed a written request with Beighley for Enbrel, and stated that he was in intense pain from his joints swelling (he described his pain, “Pm walking on bone on bone and have a lot of pain in my knee”), had not been provided a substitute for Enbrel, and had not been seen by the orthopedic specialist as promised. He requested that he be seen by either a rheumatologist or an orthopedic specialist so he could get an injection in his knee to relieve the pain. Beighley responded, “You are on the list to be seen by the ortho.” On July 26, Arnett was evaluated by an orthopedic surgeon for complaints of right knee pain related to his RA condition and the surgeon injected Arnett’s knee with Depo-Medrol.
Arnett began seeing Physician’s Assistant Paul-Blanc on a daily basis beginning in May 2007. Each time he saw PaulBlanc, Arnett reiterated his plea for Enbrel and stated that because he had not been taking the drug, his joints were swollen and he was in intense pain. PaulBlanc1 agreed that Arnett’s joints were swollen. In response to Arnett’s requests, Paul-Blanc stated that a request for the drug had been made but that he had not yet heard anything from Washington, D.C. Starting in May 2007, Arnett also went to Case Manager Parker two to three times a week and requested that he be placed on Enbrel. Parker told him to “talk to Blanc.” Arnett also filed an administrative claim for damages with Parker, which Parker denied. Arnett appealed to Veach, who also denied the claim.
On September 5, 2007, upon Arnett’s request, Dr. Bergquist (Arnett’s former physician) wrote a letter to the prison (“To Whom it May Concern”) that Arnett attached to his complaint. Dr. Bergquist stated that Arnett had been under his care for RA since June 2001, that he had been on numerous medications and either did not tolerate the medications or did not show improvement, and that when taking Enbrel, his joint pain and swelling decreased. Dr. Bergquist pointed out that RA is a progressive disease and if the pain and swelling of the joints is not controlled, further joint damage can occur. He concluded that he thought it “appropriate for Mr. Arnett to be reevaluated by a rheumatologist to help make the decision as to the best treatment for Mr. Arnett’s rheumatoid arthritis.” Apparently in response to Dr. Bergquist’s letter, the prison finally gave Arnett an injection of Enbrel. He was released from prison eleven days later on October 16.
Arnett alleged that the “intentional refusal by the Federal Bureau of Prison’s *749 personnel to give [him] the medication Enbrel ... constitute^] a deliberate indifference to [his] obvious medical condition by those defendants, thereby resulting in substantial pain and suffering ... and irreversible physical damage and deformity of his joints.” He asserted that he was simply left untreated during this ten-month plus delay while he “unnecessarily suffered from continual and ongoing pain and advancing physical deterioration” in violation of the Eighth Amendment.
We now turn to the summary judgment record, supplementing the facts set forth above only where necessary and construing those facts in light most favorable to Arnett. When Arnett arrived at Terre Haute, he had several medical problems in addition to RA, including chronic Hepatitis C, which resulted in over twenty-two encounters with the medical department or medical consultations with specialists during his stay at Terre Haute. Dr. Webster did a full physical exam on Arnett a few days after he self-surrendered at the prison and again on November 16. Dr. Webster reviewed Arnett’s medical records, and Arnett informed him that he was previously prescribed Enbrel and that this drug was effective in controlling his RA and alleviating the pain and swelling in his joints. (Dr. Webster disputes any awareness that Arnett was taking Enbrel before his arrival at the prison, but Arnett has presented evidence supporting this fact, and we must accept it as true.) Dr. Webster was also aware that Arnett had been taking the drug Gabapentin to treat neuropathy (nerve damage) and resulting nerve pain. Gabapentin, like Enbrel, was not on the prison’s approved formulary. When a drug is not on the approved list, a physician wanting to prescribe the medication must submit a non-formulary drug authorization request to the BOP for approval. Dr. Webster completed such a request for Gabapentin and authorized Arnett’s temporary continued use of the drug for fourteen days, pending the decision of the nonformulary request. Dr. Webster did not submit a request for Enbrel. He issued Arnett a pass for a lower bunk, renewed his pain medication Percocet, ordered x-rays, and submitted an approval for a consultation with a rheumatologist to the prison review committee.
Arnett was then assigned to Dr. Wilson. Arnett’s medical chart on December 28, 2006, indicates: “RA; referral to rheumatology pending, trying to get Enbrel but need this consult first as central office requires it (it is obvious he has RA).” As discussed above, the request for an outside consultation was approved and Arnett saw Dr. Davis in February 2007. Dr. Webster averred that he was not Arnett’s primary care physician and “had no personal involvement with Plaintiffs medical care other than reviewing his chart and medications when he first arrived at FCC Terre Haute.” He reiterated, “I was not Plaintiffs primary care physician and had no involvement with the request for Enbrel.” A few weeks after his February 2007 exam by Dr. Davis, however, Arnett saw Dr. Webster in the medical unit and pointed out that Dr. Davis stated he should be placed back on Enbrel. Arnett asked Dr. Webster what he had done about getting approval for Enbrel and Dr. Webster responded, “We’re working on it.”
Arnett’s prescription for Percocet continued to be renewed. The non-formulary request for Gabapentin was denied, so he was instead prescribed a new pain medication, Topamax, in December 2006. These drugs were prescribed for their use in alleviating pain, not reducing inflammation or slowing the progression of RA. In April 2007, Arnett was seen during sick call for complaints of right knee pain; x-rays were ordered and a consent for orthopedic consultation was completed. On July 9, Arnett was evaluated during a *750 chronic care clinic visit. The record indicates that he continued to complain of joint pain and pressure in his knees and that he “[w]as to receive Enbrel but hasn’t. Never heard back from the non-formulary request.” The record further indicates “Request Enbrel again” and “Request follow up with rheumatology.” It then reads, “Start: Enbrel 15 mg sq per week (non formulary submitted).” In July, Dr. Webster also signed a record of medical care stating that the utilization review committee approved a follow-up appointment with Dr. Davis to consult for RA “ASAP.” A consultation sheet that same day states “Schedule follow up consult for [RA] ... Advised to start Enbrel.” Dr. Wilson submitted a request for a follow up consultation with Dr. Davis. Arnett’s medical charts indicate that he was finally given Enbrel on October 5, 2007. He was transferred to a half-way house on October 16.
II. Discussion
The district court dismissed Warden Veach from this action on the basis that he only had an administrative role and dismissed all the other defendants, except Dr. Webster, on the basis that there was no allegation in the complaint suggestive that these defendants acted with the requisite mental state of deliberate indifference to support a claim under the Eighth Amendment. The district court (after the case was transferred to a different judge) then granted summary judgment in favor of Dr. Webster reasoning that Arnett failed to submit evidence showing a genuine issue of material fact that Dr. Webster was deliberately indifferent to his serious medical needs. We agree that Arnett failed to state a claim against the non-medical defendants, Veach and Parker, but disagree that Arnett’s allegations were insufficient to state a claim against the medical defendants, Dr. Wilson, Beighley, and PaulBlanc. We agree, however, that the record on summary judgment is insufficient to allow a reasonable jury to infer that Dr. Webster acted with deliberate indifference.
“The Eighth Amendment safeguards the prisoner against a lack of medical care that ‘may result in pain and suffering which no one suggests would serve any penological purpose.’ ”
Rodriguez v. Plymouth Ambulance Serv.,
The defendants don’t disagree that Arnett suffered from a serious medical condition.
See Norfleet v. Webster,
A prisoner, however, “need not prove that the prison officials intended, hoped for, or desired the harm that transpired.”
Walker v. Benjamin,
A. Section 1915(e)(2) Screening of Complaint
Our review of a dismissal under § 1915(e)(2)(B) for failure to state a claim is de novo.
DeWalt v. Carter,
Recent cases instruct us to examine whether the allegations in the complaint state a “plausible” claim for relief.
Iqbal,
Based on a review of Arnett’s complaint and attached documents we have no trouble finding that he stated a claim against medical defendants, Dr. Wilson, Beighley, and Paul-Blanc, for violations under the Eighth Amendment. The defendants knew that Arnett had RA and was in continuous pain as a result of the inflammation in his joints; yet, they didn’t provide him medication to treat his underlying condition, not Enbrel as he requested and Dr. Davis instructed, nor any other substitute medication. (In his appellate brief, Arnett describes Dr. Davis’ comment as a “recommendation,” but construing the facts in light most favorable to Arnett, we prefer to refer to it as an “instruction.” After all, Dr. Davis is a RA specialist who Arnett specifically went to see for a consultation. When Dr. Davis said “I would like” for Arnett to resume a specific dosage of Enbrel once a week, that can reasonably be inferred to be an instruction.) Arnett was not provided effective treatment of his RA until October 2007, over ten months after he arrived at Terre Haute and first sought treatment. The summary judgment record indicates that Arnett was given pain medication, but he was reasonably seeking medication to treat, not simply mask, his condition. 5 Even though he informed prison officials that the pain medication was not working, they persisted in a course of treatment, according to Arnett’s allegations, known to be ineffective. Arnett alleged that the defendants intentionally refused to provide him with Enbrel and their refusal to treat him caused him substantial pain and suffering, including irreversible physical damage and deformity of his joints. These facts are sufficient to state a claim.
It is not clear why the complaint was allowed to go forward against Dr. Webster *753 but not the other medical defendants. We are particularly curious about the district court’s reasoning for dismissing Dr. Wilson, Arnett’s primary care physician at the prison. Dr. Wilson was aware of Arnett’s condition, his need for treatment, and his pleas for Enbrel. In fact, Dr. Davis wrote a letter addressed to Dr. Wilson in February 2007 instructing that Arnett be placed back on Enbrel. The letter explained the severity of Arnett’s condition, the associated pain, and the need for treatment to prevent permanent joint damage. After receiving this letter, Dr. Wilson still did nothing to treat Arnett’s RA with effective medication. As to Beighley and PaulBlanc, Arnett asked them repeatedly for Enbrel, but they simply told him that the request had been submitted to the BOP and they were waiting for a response.
Arnett has a serious medical condition and his pleas for treatment and medication were ignored for over ten months while he suffered intense pain. It appears that a request for Enbrel was made to the BOP, but then languished. It is unclear who caused the delay or who was responsible for following-up with the request, but what we do know is that Arnett didn’t receive an Enbrel injection until October 2007. Deliberate indifference can include the intentional delay in access to medical care.
Rodriguez,
Allegations of refusal to provide an inmate with prescribed medication or to follow the advice of a specialist can also state an Eighth Amendment claim.
See Wynn v. Southward,
Although the defendants provided him pain medicine, a medical professional’s actions may reflect deliberate indifference if he “chooses an easier and less efficacious treatment without exercising professional judgment.”
See McGowan,
Arnett has an inflammatory condition, yet he was never provided anti-inflammatory medication, not even aspirin, a well-known and readily available NSAID. Ar-nett wasn’t seeking an unconventional treatment; he sought medication that would reduce his pain and swelling and slow the progression of his RA. Although an inmate is not entitled to demand specific care and is not entitled to the best care possible, he is entitled to reasonable measures to meet a substantial risk of serious harm.
Forbes v. Edgar,
Maybe Arnett will be unable to support his factual allegations with admissible evidence. Maybe Beighley and Paul-Blanc properly relied on the advice of Dr. Wilson. Maybe Dr. Wilson can show that he legitimately explored alternative options and rejected them for valid reasons or that his treatment decisions were otherwise based on his medical judgment. These, and other questions, will need to be explored through discovery. Whether Ar-nett can support his allegations that the medical defendants were deliberately indifferent remains to be seen. The district court was too hasty in dismissing his claims against the medical defendants, especially given its duty to construe pro se complaints liberally.
See McGowan,
We come to a different conclusion with respect to the non-medical defendants, Warden Veach and Case Manager Parker. Arnett conceded at oral argument that Veach was properly dismissed, so we limit our discussion to Parker. Ar-nett didn’t go so far as to say that Parker was properly dismissed, but he did concede that Parker was in a similar situation to Veach. We agree. Arnett’s allegations against Parker are minimal. He alleges that starting in May 2007, he went to Parker two to three times a week and requested that he be placed back on Enbrel. In response, Parker merely said, “Go talk to Blanc.” Parker cannot be held liable on the basis of respondeat superior; to be liable, he must be personally liable for Arnett’s injury.
See Iqbal,
Non-medical defendants, such as Parker, can rely on the expertise of medical personnel. We have previously stated that if a prisoner is under the care of medical experts, a non-medical prison official will generally be justified in believing that the prisoner is in capable hands.
Greeno,
[I]f a prisoner is under the care of medical experts ... a non-medical prison official will generally be justified in believing that the prisoner is in capable hands. This follows naturally from the division of labor within a prison. Inmate health and safety is promoted by dividing responsibility for various aspects of inmate life among guards, administrators, physicians, and so on. Holding a non-medical prison official liable in a case where a prisoner was under a physician’s care would strain this division of labor.
See also Greeno,
The allegations in Arnett’s complaint are insufficient to state a claim that Parker acted with deliberate indifference in referring Arnett to medical personnel who were treating Arnett on a regular basis. This is not a case where Arnett was being completely ignored by medical staff. Although Parker was aware, based on Arnett’s complaints, that he wasn’t receiving the specific medication he sought, Arnett doesn’t allege that Parker condoned or approved the medical staffs alleged refusal to provide him medical care, impeded their ability to provide effective treatment, or was in a position to take corrective action. Parker was able to relegate to the prison’s medical staff the provision of good medical care. See Burks v. Raemisch, 555 F.3d 592, 595 (7th Cir.2009) (“[Inmate’s] contention that any public employee who knows (or should know) about a wrong must do something to fix it is just an effort to evade, by indirection, MonelVs rule that public employees are responsible for their own misdeeds but not for anyone else’s.”). “A layperson’s failure to tell the medical staff how to do its job cannot be called deliberate indifference; it is just a form of failing to supply a gratuitous rescue service.” Id. Arnett’s allegations against Parker are simply too meager to state a claim of deliberate indifference against a non-medical defendant who referred Arnett to his treating physician’s assistant.
Maybe Arnett could have corrected the deficiencies in his complaint against Parker. Although the district court’s dismissal of Parker doesn’t indicate if it was with or without prejudice, generally, an involuntary dismissal operates as an adjudication on the merits if not otherwise indicated.
See
Fed.R.Civ.P. 41(b). But given Ar-nett’s pro se status and the fact that he may have been able to cure the deficiencies in his claim against Parker, the dismissal should have been without prejudice with leave to amend.
See Gladney v. Pendleton Corr. Facility,
Arnett, however, never sought to amend his complaint or re-file upon paying the filing fee and the district court was not required to inform him that he
should.
“District judges have no obligation to act as counsel or paralegal to
pro se
litigants.”
Myles v. United States,
B. Summary Judgment as to Dr. Webster
We review a district court’s grant of summary judgment de novo, construing all facts and reasonable inferences in the light most favorable to the non-moving party.
Spivey v. Adaptive Mktg. LLC,
As we indicated above, a defendant cannot be liable under
Bivens
on the basis of respondeat superior or supervisory liability, rather, there must be individual participation and involvement by the defendant.
See Iqbal,
Of course, [the defendant prison official] cannot be personally liable under a theory of respondeat superior. However, an official satisfies the personal responsibility requirement of section 1983 if the conduct causing the constitutional deprivation occurs at his direction or with his knowledge and consent. That is, he must know about the conduct and facilitate it, approve it, condone it, or turn a blind eye. In short, some causal connection or affirmative link between the action complained about and the official sued is necessary for § 1983 recovery.
Id.
(internal citations, quotation marks, brackets, and ellipses omitted);
see also Chavez v. Ill. State Police,
*758 Dr. Webster examined Arnett on two occasions in November 2006 at which time, Arnett informed him of his RA and need for Enbrel. Enbrel wasn’t on the prison’s formulary, so before Arnett could receive it, Dr. Webster would have had to request authorization from the BOP. Dr. Webster put in a non-formulary request for Gabapentin — a pain medication that Arnett had been taking before his arrival at Terre Haute — and continued Arnett on Gabapentin temporarily pending a decision on the non-formulary request. Dr. Webster didn’t similarly put in a request for Enbrel or continue Arnett on Enbrel temporarily. (Webster contends that’s because he wasn’t aware that Arnett had previously been prescribed Enbrel.) However, Dr. Webster did take further steps to treat Arnett: he issued him a bottom bunk pass (presumably because of his joint pain), prescribed pain medication, ordered x-rays, and submitted approval for consultation with a rheumatologist. Arnett’s medical records indicate that he needed a consultation with an outside rheumatologist before receiving Enbrel. Arnett was seen by Dr. Davis in February 2007, during which time, Dr. Wilson was his primary care physician. Arnett’s last interaction with Dr. Webster was a few weeks after his appointment with Dr. Davis when he asked Dr. Webster for Enbrel pursuant to Dr. Davis’ instructions. Dr. Webster responded, “We’re working on it.” At this time, Dr. Webster’s involvement with Arnett’s care was a passing conversation in the medical unit. 8
This record doesn’t allow for a reasonable jury to infer that Dr. Webster acted with deliberate indifference. It seems Dr. Webster may have thought a request for Enbrel had been submitted and prison medical staff were waiting for a response from the BOP after Arnett’s appointment with the rheumatologist. Dr. Webster failed to investigate further when Arnett informed him he still had not received the medication in February 2007. Given Ar-nett’s condition and repeated pleas for Enbrel, Dr. Webster should have investigated further. Although his failure to do so may amount to negligence, the summary judgment record does not lead to the conclusion that it rose to the level of deliberate indifference. “Deliberate indifference is not medical malpractice; the Eighth Amendment doesn’t codify common law torts.”
See Duckworth,
Dr. Webster provided treatment to Ar-nett when he first arrived at the Terre Haute facility. It may not have been the most appropriate treatment, but a prisoner is only entitled to reasonable measures to meet a substantial risk of serious harm.
Forbes,
Arnett also hasn’t presented facts showing that Dr. Webster was aware that the continued treatment Arnett received for his RA was ineffective. Arnett offers no evidence that Dr. Webster directly oversaw or approved Dr. Wilson’s individualized treatment decisions or in any way impeded Dr. Wilson’s ability to effectively treat Arnett. Nor is there evidence that Dr. Webster examined Arnett or reviewed his chart after November 2006 or was otherwise involved with Dr. Wilson’s medical decisions as to Arnett’s treatment regime.
Compare Minix v. Canarecci,
There must be a causal connection or affirmative link between the action complained about and the official sued and that connection is missing with respect to Dr. Webster. This isn’t a case where Dr. Webster simply walked away from the situation and left Arnett without medical care. A review of Arnett’s prison medical records indicates that he was being seen regularly by medical staff, his pain medications were being renewed, x-rays were performed, and he was examined by an outside rheumatologist and an orthopedic surgeon. Dr. Webster left Arnett in the care of other medical personnel, including a staff physician. Whether the care he received was so far afield of accepted professional standards as to raise the inference that it was not actually based on medical judgment remains to be seen. But the defendants whose medical judg *760 ment is properly being questioned is Dr. Wilson’s, and possibly Beighley’s and Paul-Blanc’s depending on their involvement in Arnett’s treatment — individuals who continued to see Arnett on a regular basis after Dr. Davis instructed that he be placed back on Enbrel.
Arnett had the burden to come forth with evidence to show that Dr. Webster was personally liable for his alleged inadequate medical treatment after December 2006, and he has failed to do so.
See Johnson v. Cambridge Indus., Inc.,
III. Conclusion
For the foregoing reasons, we Affirm dismissal of Richard Veach and David Parker for failure to state a claim, Affirm the grant of summary judgment in favor of Dr. Thomas Webster, but Reverse dismissal of Dr. Eric Wilson, Yves Paul-Blanc, and Julia Beighley, and Remand for further proceedings.
Notes
. The defendants argue that there is nothing in the record to support these facts, but they can be found in Dr. Bergquist's September 5, 2007, letter that was attached to Arnett’s complaint. We also note that several authoritative sources support this description of the disease. See The Merck Manual of Diagnosis and Therapy 283-89 (18th ed.2006) (stating that RA is a chronic autoimmune disease resulting in progressive destruction of the joints). While Arnett will need to present admissible evidence to substantiate such facts for purposes of summary judgment, he does not need to do so at the pleading stage.
. Enbrel is used to reduce the progression of RA. See The Merck Manual of Diagnosis and Therapy 289; see also Physicians’ Desk Reference 631 (65th ed.2011) ("Enbrel is indicated for reducing signs and symptoms, ... inhibiting the progression of structural damage, and improving physical function in patients with moderately or severely active [RA].”). The defendants' characterization of Enbrel as "pain medication” is a misnomer.
. This fact isn’t found in Arnett’s complaint or attached documents, but we state it here to provide relevant background information. It can be found in the summary judgment record in a letter from Dr. Bergquist dated April 20, 2009. This information is supported by Enbrel’s website and authoritative text. See http://www.enbrel.com/what-isENBREL.jspx (last visited Sept. 7, 2011) ("People with inflammatory diseases such as rheumatoid arthritis ... have too much TNF in their bodies. Enbrel reduces levels of the active form of TNF.”); see also Mosby’s Nursing Drug Reference 491-92 (25th ed.2012) (stating that Enbrel ”[b]inds [TNF], which is involved in immune and inflammatory reactions.”); Physicians' Desk Reference 639 (“Enbrel can reduce the effect of TNF in the body and block the damage that too much TNF can cause....”).
. Many of the cases cited in this opinion arose under 42 U.S.C. § 1983.
Bivens
authorizes the filing of constitutional tort suits against federal officers in much the same way that 42 U.S.C. § 1983 authorizes such suits against state officers.
Ashcroft v. Iqbal,
. The goal in treating RA “is to reduce inflammation as a means of preventing erosion and progressive deformity.” See The Merck Manual of Diagnosis and Therapy 283-89. Drug therapy for RA usually combines non-steroidal anti-inflammatory drugs (NSAIDs), which help reduce symptoms, and disease modifying antirheumatic drugs (DMARDs), which slow disease progression. See id. NSAIDs are used to control the symptoms and signs of the local inflammatory process, and DMARDS are used to modify the inflammatory component of RA and its destructive capacity. See Hairison’s Principles of Internal Medicine 2089-90 (17th ed.2008). Enbrel is a more recent type of drug that is aligned with DMARDS, but is classified as a “biological response modifier”; it is a TNF-neutralizing agent that has been shown to have a “major impact on the signs and symptoms of RA and also to slow progressive damage to articular structures.” See Hairison’s Principles of Internal Medicine 2090 (stating that TNF-neutralizing agents have been "shown to slow the rate of progression of joint damage ... and to improve disability.”). We express no opinion on the appropriate treatment for Arnett, but we cite these authoritative sources to illustrate commonly accepted treatment options for individuals with RA.
. The defendants point out that Arnett didn't submit expert opinion testimony on the damaging effects of RA and treatment options, but Arnett did attach Dr. Davis’ February 2007 letter and Dr. Bergquist’s September 2007 letter to his complaint, and while we agree that expert opinion testimony may be neces *754 sary to survive summary judgment, it is not necessary at the pleading stage.
. As clinical director, Dr. Webster presumably had supervisory authority over Dr. Wilson.
See Norfleet,
. Dr. Webster’s name does appear on Arnett’s medical charts dated March 19 and April 14, which indicated that Arnett’s pain medications were renewed. Also on July 9, the entry that indicates Arnett was to receive Enbrel, but hadn’t because the prison never heard back from the non-formulary request, indicates that labs had been requested by Dr. Webster. On July 11, Dr. Webster further signed a record of medical care stating that the utilization review committee approved a follow-up appointment with Dr. Davis to consult for RA. Arnett doesn't indicate that he saw Dr. Webster on any of these occasions or discussed his condition with Dr. Webster and there is no evidence (other than Dr. Webster's name appearing on these documents) that he was personally involved in Arnett’s care on such dates.
